Previous work has described a high incidence of STAT3 activation in ESFT [12], and we were interested in confirming this finding in an independent tissue set, as well as analysing tissue distribution of activated STAT3 within the tumor microenvironment. The gene discussed is STAT3; the disease is neoplasm.